The FDA will temporarily allow a replacement drug for Doxil, a drug for ovarian and other cancers, to be imported. The drug has not been available to new patients for months. The FDA also approved a supplier for a preservative-free version of methotrexate, which is used to treat children with acute lymphoblastic leukemia and bone cancer.
Related Articles on Supply Chain:
Cardinal Health to Start Offering its Complete Portfolio of Surgical Gloves in Sustainable, Half-Fold Packaging
Teleflex Signs Agreement With HealthTrust for Arrow Intra-Aortic Balloon Pumps and Catheters
SourceMedical Launches Vision OnDemand Clinical and Business Management System for ASCs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
